*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Minodronic acid is a potent nitrogen-containing bisphosphonate used for treating osteoporosis. Its core synthesis involves condensation reactions to form the P-C-P backbone. The molecular formula is <strong>C<sub>10</sub>H<sub>24</sub>N<sub>2</sub>O<sub>7</sub>P<sub>2</sub></strong> and CAS number is <strong>159968-17-7</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Osteoporosis Management:</strong> Inhibits osteoclast-mediated bone resorption in postmenopausal women.</li>
<li><strong>Glycemic Control:</strong> Investigated for potential benefits in diabetes-related bone complications.</li>
<li><strong>Metastatic Bone Disease:</strong> Used off-label to reduce skeletal-related events in cancer patients.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in severe renal impairment. Strict adherence to dosing intervals is required to prevent esophageal irritation. Store in a dry environment below 25°C away from direct sunlight.</p>